quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:13:20·168d
SECFiling
Carlsmed Inc. logo

SEC Form 10-Q filed by Carlsmed Inc.

CARL· Carlsmed Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CARL
    Carlsmed Inc.
    Health Care

Recent analyst ratings

  • Aug 18UpdateGoldman$19.00
  • Aug 18UpdatePiper Sandler$18.00
  • Aug 18UpdateTruist$18.00
  • Aug 18UpdateBTIG Research$21.00
  • Aug 18UpdateBofA Securities$16.00

Related

  • SEC1d
    SEC Form DEFA14A filed by Carlsmed Inc.
  • SEC1d
    SEC Form DEF 14A filed by Carlsmed Inc.
  • PR9d
    Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
  • PR22d
    Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
  • INSIDER50d
    CEO, President Cordonnier Michael exercised 391,686 shares at a strike of $0.68 and sold $2,629,889 worth of shares (197,855 units at $13.29), increasing direct ownership by 14% to 1,550,477 units (SEC Form 4)
  • SEC57d
    SEC Form S-8 filed by Carlsmed Inc.
  • SEC57d
    SEC Form 10-K filed by Carlsmed Inc.
  • PR57d
    Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022